New Drug Holds Some Promise for Treatment-Failure Gout
IV pegloticase every 2 to 4 weeks effectively controlled uric acid levels, but the incidence of adverse events was high.
Gespeichert in:
| Veröffentlicht in: | NEJM journal watch. General medicine 2008-12 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | NEJM journal watch. General medicine |
| container_volume | |
| creator | DeMarco, Deborah M |
| description | IV pegloticase every 2 to 4 weeks effectively controlled uric acid levels, but the incidence of adverse events was high. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1284438991</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2884886481</sourcerecordid><originalsourceid>FETCH-proquest_journals_12844389913</originalsourceid><addsrcrecordid>eNqNirEOgjAUADtoIlH-4SXOJNAitrOKTMZEdtKEh4EAT1_b-Psy-AHecsPdSkRSSZNIXRw2InZuSBfMMVW6iERxww-cOTyhorF18KAJ4c409Q6hI4aa0foJZ5-Uth8DI1wp-J1Yd3Z0GP-8FfvyUp-q5MX0Duh8M1DgeUlNJnWeK21Mpv67vn0ENMY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1284438991</pqid></control><display><type>article</type><title>New Drug Holds Some Promise for Treatment-Failure Gout</title><source>ProQuest Central UK/Ireland</source><creator>DeMarco, Deborah M</creator><creatorcontrib>DeMarco, Deborah M</creatorcontrib><description>IV pegloticase every 2 to 4 weeks effectively controlled uric acid levels, but the incidence of adverse events was high.</description><identifier>ISSN: 2329-2865</identifier><language>eng</language><publisher>Waltham: Massachusetts Medical Society</publisher><subject>Clinical trials ; Medical research</subject><ispartof>NEJM journal watch. General medicine, 2008-12</ispartof><rights>Copyright © 2008 Massachusetts Medical Society. All rights reserved.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1284438991?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,64384,64388,72240</link.rule.ids></links><search><creatorcontrib>DeMarco, Deborah M</creatorcontrib><title>New Drug Holds Some Promise for Treatment-Failure Gout</title><title>NEJM journal watch. General medicine</title><description>IV pegloticase every 2 to 4 weeks effectively controlled uric acid levels, but the incidence of adverse events was high.</description><subject>Clinical trials</subject><subject>Medical research</subject><issn>2329-2865</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNirEOgjAUADtoIlH-4SXOJNAitrOKTMZEdtKEh4EAT1_b-Psy-AHecsPdSkRSSZNIXRw2InZuSBfMMVW6iERxww-cOTyhorF18KAJ4c409Q6hI4aa0foJZ5-Uth8DI1wp-J1Yd3Z0GP-8FfvyUp-q5MX0Duh8M1DgeUlNJnWeK21Mpv67vn0ENMY</recordid><startdate>20081218</startdate><enddate>20081218</enddate><creator>DeMarco, Deborah M</creator><general>Massachusetts Medical Society</general><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>M0R</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20081218</creationdate><title>New Drug Holds Some Promise for Treatment-Failure Gout</title><author>DeMarco, Deborah M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_12844389913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Clinical trials</topic><topic>Medical research</topic><toplevel>online_resources</toplevel><creatorcontrib>DeMarco, Deborah M</creatorcontrib><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>NEJM journal watch. General medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DeMarco, Deborah M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>New Drug Holds Some Promise for Treatment-Failure Gout</atitle><jtitle>NEJM journal watch. General medicine</jtitle><date>2008-12-18</date><risdate>2008</risdate><issn>2329-2865</issn><abstract>IV pegloticase every 2 to 4 weeks effectively controlled uric acid levels, but the incidence of adverse events was high.</abstract><cop>Waltham</cop><pub>Massachusetts Medical Society</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2329-2865 |
| ispartof | NEJM journal watch. General medicine, 2008-12 |
| issn | 2329-2865 |
| language | eng |
| recordid | cdi_proquest_journals_1284438991 |
| source | ProQuest Central UK/Ireland |
| subjects | Clinical trials Medical research |
| title | New Drug Holds Some Promise for Treatment-Failure Gout |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T19%3A17%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=New%20Drug%20Holds%20Some%20Promise%20for%20Treatment-Failure%20Gout&rft.jtitle=NEJM%20journal%20watch.%20General%20medicine&rft.au=DeMarco,%20Deborah%20M&rft.date=2008-12-18&rft.issn=2329-2865&rft_id=info:doi/&rft_dat=%3Cproquest%3E2884886481%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1284438991&rft_id=info:pmid/&rfr_iscdi=true |